Closed Loop Medicine appoints new COO
The appointment of Kate Woolland as new Chief Operating Officer of London-based Closed Loop Medicine Ltd supports delivery of the Companys product and partnership programs.
As COO, Kate Woolland will play a pivotal role in leading collaboration across the multi-disciplinary team whilst working closely with current and future commercial partners to drive delivery of Closed Loop Medicines products to market. Bringing extensive strategic business experience, including over 13 years in healthcare, she strengthens the executive team and supports the Company as it continues to scale commercial development.
In her previous role, Kate was Chief Delivery Officer at ieso Digital Health, where she led product, design, clinical trial operations, commercial, regulatory and program management functions. During that time, she secured iesos first commercial partnerships and launched its first medical device; demonstrating capability that helped secure $53m Series B investment. Prior to this, Kate was a Partner for PA Consulting, during which time she supported the development of numerous commercial partnerships and built a healthcare system transformation consulting business. She holds a Masters in Mathematics from The University of Manchester.
